Your browser doesn't support javascript.
loading
Comprehensive characterization of a Canadian cohort of von Hippel-Lindau disease patients.
Salama, Yasser; Albanyan, Saleh; Szybowska, Marta; Bullivant, Garrett; Gallinger, Bailey; Giles, Rachel H; Asa, Sylvia; Badduke, Chansonette; Chiorean, Andreea; Druker, Harriet; Ezzat, Shereen; Hannah-Shmouni, Fady; Hernandez, Karen G; Inglese, Cara; Jani, Payal; Kaur, Yuvreet; Krema, Hatem; Krimus, Lior; Laperriere, Normand; Lichner, Zsuzanna; Mete, Ozgur; Sit, Marisa; Zadeh, Gelareh; Jewett, Michael A S; Malkin, David; Stockley, Tracy; Wasserman, Jonathan D; Xu, Wei; Schachter, Nathan F; Kim, Raymond H.
Afiliação
  • Salama Y; Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Albanyan S; Clinical and Metabolic Genetics, Hospital for Sick Children, Toronto, Ontario, Canada.
  • Szybowska M; Fred A Litwin Family Centre in Genetic Medicine, University Health Network, Toronto, Ontario, Canada.
  • Bullivant G; Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
  • Gallinger B; Clinical and Metabolic Genetics, Hospital for Sick Children, Toronto, Ontario, Canada.
  • Giles RH; Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Asa S; Department of Laboratory Medicine and Pathobiology, University Health Network, Toronto, Ontario, Canada.
  • Badduke C; Advanced Molecular Diagnostics Laboratory, Princess Margaret Hospital Cancer Centre, Toronto, Ontario, Canada.
  • Chiorean A; Clinical and Metabolic Genetics, Hospital for Sick Children, Toronto, Ontario, Canada.
  • Druker H; Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
  • Ezzat S; Department of Medicine, University Health Network, Toronto, Ontario, Canada.
  • Hannah-Shmouni F; Section 6 on Endocrinology and Genetics, National Institutes of Health, Bethesda, Mary Land.
  • Hernandez KG; Department of Medicine, University Health Network, Toronto, Ontario, Canada.
  • Inglese C; Clinical and Metabolic Genetics, Hospital for Sick Children, Toronto, Ontario, Canada.
  • Jani P; McMaster University, Hamilton, Ontario, Canada.
  • Kaur Y; Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Krema H; Department of Ophthalmology and Vision Sciences, University Health Network, University of Toronto, Toronto, Ontario, Canada.
  • Krimus L; Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Laperriere N; Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada.
  • Lichner Z; Sinai Health System, Lunenfeld-Tanenbaum Research Institute, Toronto, Ontario, Canada.
  • Mete O; Department of Laboratory Medicine and Pathobiology, University Health Network, Toronto, Ontario, Canada.
  • Sit M; Department of Ophthalmology and Vision Sciences, University Health Network, University of Toronto, Toronto, Ontario, Canada.
  • Zadeh G; Division of Neurosurgery, Toronto Western Hospital, Toronto, Ontario, Canada.
  • Jewett MAS; Department of Surgery, University Health Network, University of Toronto, Toronto, Ontario, Canada.
  • Malkin D; Department of Paediatics, Hospital for Sick Children, Toronto, Ontario, Canada.
  • Stockley T; Department of Laboratory Medicine and Pathobiology, University Health Network, Toronto, Ontario, Canada.
  • Wasserman JD; Department of Paediatics, Hospital for Sick Children, Toronto, Ontario, Canada.
  • Xu W; Department of Biostatistics, Princess Margaret Hospital Cancer Centre, Toronto, Ontario, Canada.
  • Schachter NF; Department of Medicine, University Health Network, Toronto, Ontario, Canada.
  • Kim RH; Clinical and Metabolic Genetics, Hospital for Sick Children, Toronto, Ontario, Canada.
Clin Genet ; 96(5): 461-467, 2019 11.
Article em En | MEDLINE | ID: mdl-31368132
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Prevencao_e_fatores_de_risco / Hereditariedade / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Feocromocitoma / Hemangioblastoma / Proteína Supressora de Tumor Von Hippel-Lindau / Doença de von Hippel-Lindau Tipo de estudo: Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Child / Child, preschool / Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Revista: Clin Genet Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Canadá
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Prevencao_e_fatores_de_risco / Hereditariedade / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Feocromocitoma / Hemangioblastoma / Proteína Supressora de Tumor Von Hippel-Lindau / Doença de von Hippel-Lindau Tipo de estudo: Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Child / Child, preschool / Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Revista: Clin Genet Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Canadá